416 / 1631
100
75
50
25
0
–25
–50
–75
–100
Best reduction from baseline in
target lesion (%)
Patients
BV naïve (Cohort A)
BV after auto-HSCT (Cohort B)
BV before and/or after auto-HSCT (Cohort C)
Asterisks (*) denote responders
Engert et al, EHA 2017
Phase 2 CheckMate 205
Change in Target Lesion per IRC